APP and Alzheimer disease: Research has demonstrated that FPS-ZM1 can mitigate neurodegeneration and inflammation in APP (sw/0) transgenic mouse models of AD [148] and also prevent astrocyte-induced neuronal death in mice with the hSOD1G93A gene mutation.